|
MBLAC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.777070E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.391800E-01 |
| Normal-vs-Stage2 |
4.425000E-01 |
| Normal-vs-Stage3 |
6.24009999999897E-05 |
| Normal-vs-Stage4 |
3.67159999958844E-07 |
| Stage1-vs-Stage2 |
7.904600E-01 |
| Stage1-vs-Stage3 |
1.843850E-03 |
| Stage1-vs-Stage4 |
2.40779999999274E-05 |
| Stage2-vs-Stage3 |
2.474600E-01 |
| Stage2-vs-Stage4 |
8.514200E-02 |
| Stage3-vs-Stage4 |
2.616400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.700800E-03 |
| Normal-vs-AfricanAmerican |
2.46469999964916E-07 |
| Normal-vs-Asian |
2.456000E-01 |
| Caucasian-vs-AfricanAmerican |
6.175900E-04 |
| Caucasian-vs-Asian |
9.167000E-01 |
| AfricanAmerican-vs-Asian |
2.203000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.361300E-03 |
| Normal-vs-Female |
8.419400E-03 |
| Male-vs-Female |
8.252800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.447000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.037690E-02 |
| Normal-vs-Age(61-80Yrs) |
1.970040E-02 |
| Normal-vs-Age(81-100Yrs) |
1.857740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.840500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.557800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.860400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.260200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.401400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.646000E-01 |
| Normal-vs-Grade 2 |
8.468800E-01 |
| Normal-vs-Grade 3 |
3.041900E-04 |
| Normal-vs-Grade 4 |
6.4502847507697E-12 |
| Grade 1-vs-Grade 2 |
3.363000E-01 |
| Grade 1-vs-Grade 3 |
5.320200E-01 |
| Grade 1-vs-Grade 4 |
3.216000E-03 |
| Grade 2-vs-Grade 3 |
2.042200E-03 |
| Grade 2-vs-Grade 4 |
8.86439810443562E-11 |
| Grade 3-vs-Grade 4 |
1.55732000000075E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.099200E-01 |
| Normal-vs-ccB subtype |
3.13729999978918E-07 |
| ccA subtype-vs-ccB subtype |
5.37360000940623E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.181690E-02 |
| Normal-vs-N1 |
1.664400E-02 |
| N0-vs-N1 |
1.675780E-01 |
|
|
